Suppr超能文献

采用构建-点击方法在 DNA 靶向杂交抗癌剂中产生结构和功能多样性。

Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.

机构信息

Department of Chemistry, Wake Forest University , Winston-Salem, North Carolina 27109, USA.

出版信息

J Med Chem. 2012 Nov 26;55(22):10198-203. doi: 10.1021/jm301278c. Epub 2012 Oct 25.

Abstract

An efficient screening method was developed for functionalized DNA-targeted platinum-containing hybrid anticancer agents based on metal-mediated amine-to-nitrile addition, a form of "click" chemistry. The goal of the study was to generate platinum-acridine agents for their use as cytotoxic "warheads" in targeted and multifunctional therapies. This was achieved by introducing hydroxyl, carboxylic acid, and azide functionalities in the acridine linker moiety and by varying the nonleaving groups attached to platinum. The assay, which was based on microscale reactions between 6 platinum-nitrile complexes and 10 acridine derivatives, yielded a small library of 60 platinum-acridines. Reactions were monitored, and product mixtures were quantitatively analyzed by automated in-line high-performance liquid chromatography-electrospray mass spectrometry (LC-ESMS) analysis and subjected to cell viability screening using a nonradioactive cell proliferation assay. The new prescreening methodology proves to be a powerful tool for establishing structure-activity relationships and for identifying target compounds.

摘要

一种基于金属介导的胺到腈加成的“点击”化学形式的高效筛选方法,已经被开发出来,用于功能化的针对 DNA 的含铂混合抗癌药物。本研究的目的是生成铂吖啶试剂,将其用作靶向和多功能治疗中的细胞毒性“弹头”。这是通过在吖啶连接基部分引入羟基、羧酸和叠氮基官能团,并改变连接到铂上的非离去基团来实现的。该测定法基于 6 种铂-腈配合物和 10 种吖啶衍生物之间的微尺度反应,得到了一个由 60 种铂-吖啶组成的小型文库。通过自动在线高效液相色谱-电喷雾质谱(LC-ESMS)分析监测反应,并对产物混合物进行定量分析,并使用非放射性细胞增殖测定法进行细胞活力筛选。新的预筛选方法被证明是建立结构-活性关系和鉴定靶化合物的有力工具。

相似文献

1
Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents.
J Med Chem. 2012 Nov 26;55(22):10198-203. doi: 10.1021/jm301278c. Epub 2012 Oct 25.
2
Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.
Chemistry. 2014 Dec 1;20(49):16174-87. doi: 10.1002/chem.201404845. Epub 2014 Oct 10.
5
Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.
Angew Chem Int Ed Engl. 2020 Dec 1;59(49):21965-21970. doi: 10.1002/anie.202009983. Epub 2020 Sep 29.
7
Effect of linkage geometry on biological activity in thiourea- and guanidine-substituted acridines and platinum-acridines.
Bioorg Med Chem Lett. 2008 Jul 1;18(13):3799-801. doi: 10.1016/j.bmcl.2008.05.043. Epub 2008 May 16.
8
Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.
ChemMedChem. 2021 Jan 19;16(2):412-419. doi: 10.1002/cmdc.202000637. Epub 2020 Oct 22.
9
Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
Inorg Chem. 2019 Jan 7;58(1):43-46. doi: 10.1021/acs.inorgchem.8b02717. Epub 2018 Dec 13.

引用本文的文献

1
Development of Prodrug-Payloads for Targeted Therapeutic Applications of Platinum-Acridine Anticancer Agents.
Bioconjug Chem. 2023 Oct 18;34(10):1873-1881. doi: 10.1021/acs.bioconjchem.3c00368. Epub 2023 Oct 9.
2
Therapeutic significance of molecular hybrids for breast cancer research and treatment.
RSC Med Chem. 2022 Nov 29;14(2):218-238. doi: 10.1039/d2md00356b. eCollection 2023 Feb 22.
7
Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity.
Angew Chem Int Ed Engl. 2020 Dec 1;59(49):21965-21970. doi: 10.1002/anie.202009983. Epub 2020 Sep 29.
8
Cysteine-Directed Bioconjugation of a Platinum(II)-Acridine Anticancer Agent.
Inorg Chem. 2019 Jan 7;58(1):43-46. doi: 10.1021/acs.inorgchem.8b02717. Epub 2018 Dec 13.
10
Design and cellular studies of a carbon nanotube-based delivery system for a hybrid platinum-acridine anticancer agent.
J Inorg Biochem. 2016 Dec;165:170-180. doi: 10.1016/j.jinorgbio.2016.07.016. Epub 2016 Jul 27.

本文引用的文献

4
Next-generation anticancer metallodrugs.
Curr Top Med Chem. 2012;12(3):219-35. doi: 10.2174/156802612799078964.
5
Bioorthogonal reaction pairs enable simultaneous, selective, multi-target imaging.
Angew Chem Int Ed Engl. 2012 Jan 23;51(4):920-2. doi: 10.1002/anie.201104389. Epub 2011 Dec 12.
6
Development of self-immolative dendrimers for drug delivery and sensing.
J Control Release. 2012 Apr 30;159(2):154-63. doi: 10.1016/j.jconrel.2011.11.032. Epub 2011 Dec 1.
7
Unusual Reactivity of a Potent Platinum-Acridine Hybrid Antitumor Agent.
ACS Med Chem Lett. 2011 Sep 8;2(9):687-691. doi: 10.1021/ml200104h.
8
Unique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.
Metallomics. 2011 Jul;3(7):650-5. doi: 10.1039/c1mt00012h. Epub 2011 Apr 26.
9
Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay.
J Biol Inorg Chem. 2011 Mar;16(3):373-80. doi: 10.1007/s00775-010-0733-z. Epub 2010 Nov 18.
10
Antibody-drug conjugates: targeted drug delivery for cancer.
Curr Opin Chem Biol. 2010 Aug;14(4):529-37. doi: 10.1016/j.cbpa.2010.06.170. Epub 2010 Jul 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验